Stefanie Paganelli
Associate Manager
Expertise:
As an Associate Manager on the Value & Evidence team at EVERSANA, Stefanie contributes to evidence synthesis projects that support global Health Economics and Outcomes Research (HEOR) initiatives.
Since joining EVERSANA in 2021, Stefanie has been involved in various evidence synthesis activities related to pharmaceutical and medical device research. Her responsibilities include supporting systematic and targeted literature reviews, feasibility assessments and indirect treatment comparisons. She has developed high-quality deliverables such as technical reports, manuscripts, and conference presentations for publication. Her work spans multiple therapeutic areas, including oncology (prostate cancer, multiple myeloma, leukemia and lymphoma) as well as dermatitis, nasal polyps and degenerative spine disease.
Stefanie holds an Honors BSc in Health Sciences with a minor in Biology and Chemistry from Wilfrid Laurier University.
Articles by Stefanie Paganelli
Filling in the Gaps: Predicting Treatment Effects From Surrogate Endpoints
Over the past 15 years, the treatment landscape for first-line metastatic castration-resistant prostate cancer (mCRPC) has undergone significant changes, marked by the approval and investigation of several new therapies. With multiple pharmacological treatments available for first-line mCRPC, network meta-analyses (NMAs) can serve as a valuable resource for evaluating clinical effectiveness that reflects current and local […]